drugs in pediatrics

18
 Drugs in Pediatrics NMT11 www.MedadTeam.org 1 Respiratory TB TB TB TB Treatment Treatment Treatment Treatment: Combined  drug therapy for Long  time: 2 to to to to 3 3 first line drugs for at least 6 6 6- - -9 9 months months months months. 1 1- - - First line drugs are First line drugs are First line drugs are First line drugs are:  Dose Dose Dose Dose Route Route Route Route Side effect Side effect Side effect Side effect  Isoniazid Isoniazid Isoniazid Isoniazid 10-20 mg/kg/day orally Hepatotoxicity  Rifampicin Rifampicin Rifampicin Rifampicin 10-20 mg/kg/day orally Hepatotoxicity  Pyrazinamide Pyrazinamide Pyrazinamide Pyrazinamide 20 20 20 20- - -40 40 40 40 mg/kg/day orally Hepatotoxicity 2 2 2- - Second line drugs are: Second line drugs are: Second line drugs are: Second line drugs are:  Dose Dose Dose Dose Route Route Route Route Side effect Side effect Side effect Side effect  Ethambutol Ethambutol Ethambutol Ethambutol 10-20 mg/kg/day orally  Ethionamide Ethionamide Ethionamide Ethionamide 10-20 mg/kg/day orally  Streptomycin Streptomycin Streptomycin Streptomycin 20 20 20 20- - -40 40 40 40 mg/kg/day IM IM IM IM Ototoxicity, Nephrotoxicity Ototoxicity, Nephrotoxicity Ototoxicity, Nephrotoxicity Ototoxicity, Nephrotoxicity  Kanamycin Kanamycin Kanamycin Kanamycin Bronchial Bronchial Bronchial Bronchial  asthma asthma asthma asthma TTT of acute attack: TTT of acute attack: TTT of acute attack: TTT of acute attack: A A A A- - -Acute mild to moderate attack Acute mild to moderate attack Acute mild to moderate attack Acute mild to moderate attack: 1 1- - -Bronchodilators Bronchodilators Bronchodilators Bronchodilators: Dose Dose Dose Dose Route Route Route Route Action Action Action Action  B- - - -agonist: agonist: agonist: agonist: Salbutamol, Salbutamol, Salbutamol, Salbutamol, Terbutaline, Terbutaline, Terbutaline, Terbutaline, Fenoterol Fenoterol Fenoterol Fenoterol 0.1-0.2 mg/kg/d - Orally in mild attack - Nebulizer for infants and young children - Inhalers for older children Selective B agonist  Theophylline Theophylline Theophylline Theophylline (methylxanthine (methylxanthine (methylxanthine (methylxanthine derivatives) derivatives) derivatives) derivatives) 15-20 mg/kg/d orally or rectally direct relaxation of bronchial Sm.Ms  Anticholinergic: Anticholinergic: Anticholinergic: Anticholinergic: Ipratropium Ipratropium Ipratropium Ipratropium 250 microgram/dose, 4times daily Inhalation Reduce the intrinsic vagal tone 2 2 2 2- - - -Corticosteriods Corticosteriods Corticosteriods Corticosteriods: In moderate or severe cases orally or parenterally orally or parenterally orally or parenterally orally or parenterally  (anti-inflammatory and interfere with synthesis of LKs& PGs) N.B: N.B: N.B: N.B: Mild cases>>one or 2 bronchodilators are given, inhaled bronchodilator are the best Moderate cases>>inhaled bronchodilator and oral corticosteroids can be used

Upload: karla-sanchez

Post on 18-Jul-2015

110 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Drugs in Pediatrics

5/16/2018 Drugs in Pediatrics - slidepdf.com

http://slidepdf.com/reader/full/drugs-in-pediatrics 1/18

 

Drugs in Pediatrics NMT11

www.MedadTeam.org 1

Respiratory

TBTBTBTB

TreatmentTreatmentTreatmentTreatment::::

Combined drug therapy for Long time: 2222 totototo 3333 first line drugs for at least 6666----9999 monthsmonthsmonthsmonths.

1111----  First line drugs areFirst line drugs areFirst line drugs areFirst line drugs are::::

 

DoseDoseDoseDose RouteRouteRouteRoute Side effectSide effectSide effectSide effect

•  IsoniazidIsoniazidIsoniazidIsoniazid 10-20 mg/kg/day orally Hepatotoxicity

•  RifampicinRifampicinRifampicinRifampicin 10-20 mg/kg/day orally Hepatotoxicity

•  PyrazinamidePyrazinamidePyrazinamidePyrazinamide 20202020----40404040 mg/kg/day orally Hepatotoxicity

2222----  Second line drugs are:Second line drugs are:Second line drugs are:Second line drugs are:

 

DoseDoseDoseDose RouteRouteRouteRoute Side effectSide effectSide effectSide effect

•  EthambutolEthambutolEthambutolEthambutol 10-20 mg/kg/day orally

•  EthionamideEthionamideEthionamideEthionamide 10-20 mg/kg/day orally

•  StreptomycinStreptomycinStreptomycinStreptomycin 20202020----40404040 mg/kg/day IMIMIMIM Ototoxicity, NephrotoxicityOtotoxicity, NephrotoxicityOtotoxicity, NephrotoxicityOtotoxicity, Nephrotoxicity

•  KanamycinKanamycinKanamycinKanamycin

 

BronchialBronchialBronchialBronchial asthmaasthmaasthmaasthma 

TTT of acute attack:TTT of acute attack:TTT of acute attack:TTT of acute attack:AAAA----Acute mild to moderate attackAcute mild to moderate attackAcute mild to moderate attackAcute mild to moderate attack::::

1111----BronchodilatorsBronchodilatorsBronchodilatorsBronchodilators:

DoseDoseDoseDose RouteRouteRouteRoute ActionActionActionAction

•  BBBB----agonist:agonist:agonist:agonist:

Salbutamol,Salbutamol,Salbutamol,Salbutamol,

Terbutaline,Terbutaline,Terbutaline,Terbutaline,

FenoterolFenoterolFenoterolFenoterol

0.1-0.2 mg/kg/d -  Orally in mild attack

-  Nebulizer for infants and

young children

-  Inhalers for older children

Selective B

agonist

•  TheophyllineTheophyllineTheophyllineTheophylline

(methylxanthine(methylxanthine(methylxanthine(methylxanthine

derivatives)derivatives)derivatives)derivatives)

15-20 mg/kg/d orally or rectally direct

relaxation of 

bronchialSm.Ms

•  Anticholinergic:Anticholinergic:Anticholinergic:Anticholinergic:

IpratropiumIpratropiumIpratropiumIpratropium

250 microgram/dose,

4times daily

Inhalation Reduce the

intrinsic vagal

tone

2222----CorticosteriodsCorticosteriodsCorticosteriodsCorticosteriods:

In moderate or severe cases orally or parenterally orally or parenterally orally or parenterally orally or parenterally (anti-inflammatory and interfere with

synthesis of LKs& PGs)

N.B:N.B:N.B:N.B: Mild cases>>one or 2 bronchodilators are given, inhaled bronchodilator are the best

Moderate cases>>inhaled bronchodilator and oral corticosteroids can be used

Page 2: Drugs in Pediatrics

5/16/2018 Drugs in Pediatrics - slidepdf.com

http://slidepdf.com/reader/full/drugs-in-pediatrics 2/18

 

Drugs in Pediatrics NMT11

www.MedadTeam.org 2

BBBB----Acute severe attack (status asthmatics)Acute severe attack (status asthmatics)Acute severe attack (status asthmatics)Acute severe attack (status asthmatics)::::

-Drugs:

 

DoseDoseDoseDose RouteRouteRouteRouteIntermittent BIntermittent BIntermittent BIntermittent B2222 agonistagonistagonistagonist

nebulized Salbutamolnebulized Salbutamolnebulized Salbutamolnebulized Salbutamol

0.25-0.5 ml added to 2-3 ml saline every 1-2 h inhalation

theophyllinetheophyllinetheophyllinetheophylline 5 mg/k/6 hr IV slowly

hydrocortisonehydrocortisonehydrocortisonehydrocortisone 5-10mg/kg/6 hr IV

Preventive TTT in between attacksPreventive TTT in between attacksPreventive TTT in between attacksPreventive TTT in between attacks:

AntiAntiAntiAnti----inflammatory drugsinflammatory drugsinflammatory drugsinflammatory drugs: it is indicated in persistant asthma

1111----Corticosteriods:Corticosteriods:Corticosteriods:Corticosteriods:

 

DoseDoseDoseDose RouteRouteRouteRoutebeclomethazonebeclomethazonebeclomethazonebeclomethazone 200-800 microgram/d (4 doses/d) inhaled

BudesinideBudesinideBudesinideBudesinide 200-800 microgram/d (2 doses)

FluticasoneFluticasoneFluticasoneFluticasone 100-500 microgram/d (2 doses)

PrednisonePrednisonePrednisonePrednisone 2mg/kg/d divided doses for 3-10 days oral

2222----AntileukotrinesAntileukotrinesAntileukotrinesAntileukotrines:

DoseDoseDoseDose RouteRouteRouteRoute

Montelukast (Singulair)Montelukast (Singulair)Montelukast (Singulair)Montelukast (Singulair) 5-10mg (once daily) orally

3333----Mast cell stabilizersMast cell stabilizersMast cell stabilizersMast cell stabilizers:

DoseDoseDoseDose RouteRouteRouteRoute

KetotifenKetotifenKetotifenKetotifen 0.06mg/kg/d orally

Na cromoglycateNa cromoglycateNa cromoglycateNa cromoglycate 5-20mg/dose (3-4 doses/d) inhalation

Cardiology

Rheumatic feverRheumatic feverRheumatic feverRheumatic fever

1111----PreventionPreventionPreventionPrevention: (very imp.)

- Prevention of streptococcal infection e.g. proper ventilation

- Early diagnosis of strept. Pharyngitis , then,

- Adequate TTT by:

Benzathine penicillinBenzathine penicillinBenzathine penicillinBenzathine penicillin 1,200,000 IM single injection

OR

Benzathine penicillinBenzathine penicillinBenzathine penicillinBenzathine penicillin 1,200,000 oral at least 10 d

In Allergic Pt.

- Prevention of rheumatic activity in pts with history if R.F.:

 

ErythromycineErythromycineErythromycineErythromycine 50mg/kg/d

Page 3: Drugs in Pediatrics

5/16/2018 Drugs in Pediatrics - slidepdf.com

http://slidepdf.com/reader/full/drugs-in-pediatrics 3/18

 

Drugs in Pediatrics NMT11

www.MedadTeam.org 3

Benzathine penicillinBenzathine penicillinBenzathine penicillinBenzathine penicillin 1,200,000 IM every 2-3 weeks for life

2222----Supportive TTTSupportive TTTSupportive TTTSupportive TTT:- Rest: pts with carditis should have absolute bed rest for at least 4 weeks,

Daily examination is important to detect carditis that usually present within 2w of onset

3333----Specific TTTSpecific TTTSpecific TTTSpecific TTT:

AAAA----Arthritis onlyArthritis onlyArthritis onlyArthritis only (or carditis without cardiomgaly):

 

SalicylatesSalicylatesSalicylatesSalicylates 100mg/kg for 2w then 74mg/kg for 4-6 w

BBBB----Carditis with cardiomegaly or failureCarditis with cardiomegaly or failureCarditis with cardiomegaly or failureCarditis with cardiomegaly or failure:

 

PrednisonePrednisonePrednisonePrednisone 2mg/kg/d for 2-3w then taper

SalicylatesSalicylatesSalicylatesSalicylates 75mg/kg/d during tapering 1m after stopping Prednisone

CCCC----ChoreaChoreaChoreaChorea:

PhenobarbitonePhenobarbitonePhenobarbitonePhenobarbitone 3-5 mg/kg/d

HaloperidolHaloperidolHaloperidolHaloperidol 0.02-0.1 mg/kg/d (in pts over 12 years)

4444----TTT of complicationsTTT of complicationsTTT of complicationsTTT of complications: H.F

- Mild cases: complete bed rest, o2, fluid restrictions and steroids

- Sever cases:

 

DoseDoseDoseDose ActionActionActionAction

furosemidefurosemidefurosemidefurosemide 2mg/kg/d Preload reducing agents(diuretics)

digoxindigoxindigoxindigoxin Digitalizing dose : 0.02-0.05 mg/kg Inotropes

maintenance dose: 0.01 mg/kg/d

captoprilcaptoprilcaptoprilcaptopril may be given After load reducing agents

Infective endocarditisInfective endocarditisInfective endocarditisInfective endocarditis

  PreventionPreventionPreventionPrevention

•  Dental procedures and surgery:

DoseDoseDoseDose RouteRouteRouteRoute TimingTimingTimingTimingAmoxicillinAmoxicillinAmoxicillinAmoxicillin 50mg/kg (single large dose) oral 1 h. before the procedure

  SpecificSpecificSpecificSpecific: immediate parenteral antibiotic for 6 weeks

 

DoseDoseDoseDose RouteRouteRouteRoute DurationDurationDurationDuration

Penicillin GPenicillin GPenicillin GPenicillin G 300000 IU/kg/day

parenteral  for 6 weeksOxacillinOxacillinOxacillinOxacillin 200mg/kg/day

GentamicinGentamicinGentamicinGentamicin 2 mg/kg/day

This treatment is modified according to the results of blood culture

Page 4: Drugs in Pediatrics

5/16/2018 Drugs in Pediatrics - slidepdf.com

http://slidepdf.com/reader/full/drugs-in-pediatrics 4/18

 

Drugs in Pediatrics NMT11

www.MedadTeam.org 4

Hepatology

Chronic hepatitisChronic hepatitisChronic hepatitisChronic hepatitis•  Antiviral drugsAntiviral drugsAntiviral drugsAntiviral drugs in chronic HBV, HCV have limited response (25%)

•  Immunosuppressive (e.g. corticosteroidsImmunosuppressive (e.g. corticosteroidsImmunosuppressive (e.g. corticosteroidsImmunosuppressive (e.g. corticosteroids----azathioprineazathioprineazathioprineazathioprine) in autoimmune hepatitis

•  DDDD----penicillamine (copper chelating agent) in Wilson disease.penicillamine (copper chelating agent) in Wilson disease.penicillamine (copper chelating agent) in Wilson disease.penicillamine (copper chelating agent) in Wilson disease. It is the only curable chronic

liver disease and it should be excluded in every case of chronic hepatitis

•  Liver implantationLiver implantationLiver implantationLiver implantation in end stage liver disease

CholestasisCholestasisCholestasisCholestasis1111----  Treatment of correctable conditionsTreatment of correctable conditionsTreatment of correctable conditionsTreatment of correctable conditions

•  Antibiotics for septicemia.

•  Elimination of lactose from diet in galactosemia•  Surgical treatment of Choledochal cyst

2222----  Extrahepatic biliary atresiaExtrahepatic biliary atresiaExtrahepatic biliary atresiaExtrahepatic biliary atresia

 

•  Correctable lesion (rare): direct drainage.

•  No correctable lesion: kasia (hepatoportoenterostomy).it should be done before 60 daysto obtain best results.

•  Liver transplantation for end stage liver disease ( biliary atresia is the commonest

indication )

3333----  SupSupSupSupportive treatmentportive treatmentportive treatmentportive treatment

 

Nutritional supportNutritional supportNutritional supportNutritional support

 

• Fat soluble vitamins defeciency is replaced by synthetic water soluble preparations(e.g. for vit A and K) active vit D and vit E is given by injection .

•  Medium chain triglycerides containing formulas.

•  Calcium, zinc and Phosphorus.

PruritusPruritusPruritusPruritus

•  Phenobarbitone

•  Cholestramine ( bile acid binder )

Portal hypertensionPortal hypertensionPortal hypertensionPortal hypertension1111---- Management of variceal hemorrhageManagement of variceal hemorrhageManagement of variceal hemorrhageManagement of variceal hemorrhage::::

  Emergency therapy for bleeding varicesEmergency therapy for bleeding varicesEmergency therapy for bleeding varicesEmergency therapy for bleeding varices::::

 

. Anti shock measures: blood transfusion, intravenous fluids.. Correction of coagulopathy: vitamin k, fresh plasma, platelets transfusion

. Nasogastric tube placement

. Vasopressin infusion if bleeding persist

  Emergency endoscopyEmergency endoscopyEmergency endoscopyEmergency endoscopy and either injection sclerotherapy or band ligation

 

  Emergency shuntEmergency shuntEmergency shuntEmergency shunt:::: protosystemic shunt

 

2222---- Prevention of bleeding from varicesPrevention of bleeding from varicesPrevention of bleeding from varicesPrevention of bleeding from varices::::

 

  Prevention of the first attack of bleedingPrevention of the first attack of bleedingPrevention of the first attack of bleedingPrevention of the first attack of bleeding

 

. Avoid aspirin and non steroid anti inflammatory drugs

. B adrenergic blockers (propranolol) to lower the pressure in portal area

. Prophylactic sclerotherapy or band ligation

Page 5: Drugs in Pediatrics

5/16/2018 Drugs in Pediatrics - slidepdf.com

http://slidepdf.com/reader/full/drugs-in-pediatrics 5/18

 

Drugs in Pediatrics NMT11

www.MedadTeam.org 5

  prevention of reprevention of reprevention of reprevention of re---- bleedingbleedingbleedingbleeding: in addition to above measures, the following may needed:: in addition to above measures, the following may needed:: in addition to above measures, the following may needed:: in addition to above measures, the following may needed:

.

 

Surgical protosystemic shunt. .Liver transplantation.

Nephrology

Minimal change nephrotic syndromeMinimal change nephrotic syndromeMinimal change nephrotic syndromeMinimal change nephrotic syndrome  Home managementHome managementHome managementHome management:::: for most cases

 

  HospitalizationHospitalizationHospitalizationHospitalization:::: indicated for the first attack or relapses with marked edema

 

1111---- Supportive treatmentSupportive treatmentSupportive treatmentSupportive treatment::::

 

.... DietDietDietDiet:::: rich in protein to compensate for protein loss & salt free

Fluid restriction is indicated only in moderate or severe cases of edema

.... Bed restBed restBed restBed rest:::: is not indicated & children with mild edema can attend school

2222---- Specific treatmentSpecific treatmentSpecific treatmentSpecific treatment::::

 

Control of edemaControl of edemaControl of edemaControl of edema::::

> Mild edema:> Mild edema:> Mild edema:> Mild edema: salt free diet is sufficient

> Moderate edema:> Moderate edema:> Moderate edema:> Moderate edema: diuretics (Furosemide) 1-2 mg/kg/day

FurosemideFurosemideFurosemideFurosemide 1-2222 mg/kg/day diuretics

> Marked edema:> Marked edema:> Marked edema:> Marked edema: intravenous salt free albumin followed by Furosemide

SteroidsSteroidsSteroidsSteroids::::

  Induction or remissionInduction or remissionInduction or remissionInduction or remission: Daily therapy: Daily therapy: Daily therapy: Daily therapy

PrednisonePrednisonePrednisonePrednisone 2222 mg/kg/day (60 mg/m2 /day) divided into 3-4 doses

Respose: urine becomes free of albumin usually occurs after 2 weeks. Therapy is continued

for 1 week after that No respose after 1 month: Steroid resistant (renal biopsy is indicated)

MinimalMinimalMinimalMinimal lesionlesionlesionlesion typetypetypetype usuallyusuallyusuallyusually givesgivesgivesgives excellentexcellentexcellentexcellent resposeresposeresposerespose totototo corticosteroidscorticosteroidscorticosteroidscorticosteroids

 

  Maintenance of remissionMaintenance of remissionMaintenance of remissionMaintenance of remission: Alternate day therapy: Alternate day therapy: Alternate day therapy: Alternate day therapy

For thoseFor thoseFor thoseFor those who responded to prednisonewho responded to prednisonewho responded to prednisonewho responded to prednisone

PrednisonePrednisonePrednisonePrednisone 2222 mg/kg/day single morning dose after breakfast every other day for 3-6 ms

  RelapsesRelapsesRelapsesRelapses:::: Relapse is the recurrence of edema. It is treated as the initial attack but

 

alternate day therapy is continued for longer period ( (( (6 66 6- -- -12 12 12 12 months) months) months) months)  

 

CyclophosphamideCyclophosphamideCyclophosphamideCyclophosphamide 2222-3 mg/kg/day single dose for 8 weeks

-  in steroid resistant and in cases with frequent relapses

-  alternate day therapy with low prednisone is continued during therapy-  Total leucocytic count is monitored every week (stop therapy if count drops below

3000/mm3 

3333---- Treatment of complications: treatment of infectionsTreatment of complications: treatment of infectionsTreatment of complications: treatment of infectionsTreatment of complications: treatment of infections

 

. Antibiotics:. Antibiotics:. Antibiotics:. Antibiotics: Penicillin Penicillin Penicillin Penicillin for urgent treatment of any suspected infections (peritonitis & skin

infections)

Acute poststreptococcal glomerulonephritisAcute poststreptococcal glomerulonephritisAcute poststreptococcal glomerulonephritisAcute poststreptococcal glomerulonephritis  Home managementHome managementHome managementHome management:::: for most cases. More than 95 5 of cases will recover completely within

 

few weeks & even without therapy

Page 6: Drugs in Pediatrics

5/16/2018 Drugs in Pediatrics - slidepdf.com

http://slidepdf.com/reader/full/drugs-in-pediatrics 6/18

 

Drugs in Pediatrics NMT11

www.MedadTeam.org 6

  HospitalizationHospitalizationHospitalizationHospitalization:::: for cases complicated with severe hypertension, marked congestion or severe

 

renal failure

 Supporative treatment:Supporative treatment:Supporative treatment:Supporative treatment:

 

- RestRestRestRest: indicated only during the oliguria phase of illness (first week)

- DietDietDietDiet:

 High carbohydrate diet High carbohydrate diet High carbohydrate diet High carbohydrate diet  

 Salt & protein restriction Salt & protein restriction Salt & protein restriction Salt & protein restriction during the oliguria phase and in the presence of 

complications e.g: hypertension & marked congestion

 Fluid balance: Fluid balance: Fluid balance: Fluid balance: amount of fluids/day = urine output of the previous day + insensible

water loss (400cc/m2)

  Specific treatment:Specific treatment:Specific treatment:Specific treatment:

 

- Control of edemaControl of edemaControl of edemaControl of edema:

. In most cases edema subsides spontaneously by the end of the first week. Fluid

restriction & salt restriction during the first week are usually sufficient. Diuretics e.g: Frusemide Frusemide Frusemide Frusemide , in some cases

- Control of hypertensionControl of hypertensionControl of hypertensionControl of hypertension (when diastolic pressure exceeds 95 mmHg- usually one oral

 

antihypertensive drugs is sufficient)

CaptoprilCaptoprilCaptoprilCaptopril 0.5-1 mg/kg/day divided into 3-4 doses) ACE Inhibitor

B blockersB blockersB blockersB blockers

- For eradication of any streptococcal infection

PenicillinPenicillinPenicillinPenicillin oral 10 days course

  Treatment of complications:Treatment of complications:Treatment of complications:Treatment of complications:

 

Renal failureRenal failureRenal failureRenal failure diuretics, fluid restriction, treatment of acidosis, dialysis)

Heart failureHeart failureHeart failureHeart failure Dopamine not digitalisHypertensiveHypertensiveHypertensiveHypertensive

encephalopathyencephalopathyencephalopathyencephalopathy

I.V. Diazoxide

Chronic renal failureChronic renal failureChronic renal failureChronic renal failure Periodic clinical evaluationPeriodic clinical evaluationPeriodic clinical evaluationPeriodic clinical evaluation: nutritional status, growth, blood pressure, cariac function &

skeletal examination for rachitic changes

Laboratory evaluationLaboratory evaluationLaboratory evaluationLaboratory evaluation: blood urea, creatinine, acid base status-serum electrolytes (Na,K,Ca,P)

 

hemoglobin level & radiological examination of bones for evidence of rachitic changes

Measurement of glomerular filtration rateMeasurement of glomerular filtration rateMeasurement of glomerular filtration rateMeasurement of glomerular filtration rate: is important to determine the degree of renal

 

insufficiency:. Values between 20-30 ml/min/m2: manifestations of renal failure appear

. Values below 10 ml/min/m2 denote severe renal insufficiency

1-  Conservative measuresConservative measuresConservative measuresConservative measures: mild to moderate cases of renal insufficieny with GFR above 10

ml/min/m2 

- DietDietDietDiet:

. Carbohydrate & fat: Carbohydrate & fat: Carbohydrate & fat: Carbohydrate & fat: allowed freely to provide sufficient calories

.

 

 Protein restriction Protein restriction Protein restriction Protein restriction to dercearse the nitrogenous waste products

. Salt restriction Salt restriction Salt restriction Salt restriction in cases with hypertension

- DrugsDrugsDrugsDrugs:

Page 7: Drugs in Pediatrics

5/16/2018 Drugs in Pediatrics - slidepdf.com

http://slidepdf.com/reader/full/drugs-in-pediatrics 7/18

 

Drugs in Pediatrics NMT11

www.MedadTeam.org 7

RicketsRicketsRicketsRickets active form of Vitamin D

Growth failureGrowth failureGrowth failureGrowth failure feeding regimen-growth hormone therapy

HHHHypertensionypertensionypertensionypertension salt restriction, oral furosemide & anti-hypertensive drugsHHHHyperphsphatemia &yperphsphatemia &yperphsphatemia &yperphsphatemia &

hhhhypocalcemiaypocalcemiaypocalcemiaypocalcemia

> Oral calcium supplementation

> Vit D therapy

> Oral aluminium hydroxide

AAAAnaemianaemianaemianaemia erythropoietin & packed RBCs

AAAAcidosiscidosiscidosiscidosis oral NaHco3 

AAAAntibioticsntibioticsntibioticsntibiotics for severe urinary tract infection or severe systemic infections as it

may precipitate an episode of acute renal failure

2-  DialysisDialysisDialysisDialysis: severe renal insufficiency with GFR below 10 ml/min/m2 or when conservation

 

measures are no longer effective

- Peritoneal (continous ambulatory or chronic cycling)- Hemodialysis

 

3-  Renal transplantationRenal transplantationRenal transplantationRenal transplantation:

 

- It is the ideal therapy for children with severe renal insufficiency

- It can be carried out in children above the age of 5 years

- Problems limiting its application include: graft rejection, finding suitable donor

Urinary tract infectionUrinary tract infectionUrinary tract infectionUrinary tract infectionProper antibiotics according to culture and sensitivity

1111....  Acute casesAcute casesAcute casesAcute cases:

  PyelonephritisPyelonephritisPyelonephritisPyelonephritis:

 

DrugsDrugsDrugsDrugs DoseDoseDoseDose RouteRouteRouteRoute

GentamicxinGentamicxinGentamicxinGentamicxin

ampicillinampicillinampicillinampicillin

4 mg/kg/day

100 mg/kg/day

IV initially then shift to oral therapy

after 5 days if the patient is improving

Duration of therapy 10-14 days

Urine should be sterile within 48 hours of adequate therapy

  CystitisCystitisCystitisCystitis:

 

DrugsDrugsDrugsDrugs DoseDoseDoseDose RouteRouteRouteRoute

Amoxicillin or coAmoxicillin or coAmoxicillin or coAmoxicillin or co----trimoxazoltrimoxazoltrimoxazoltrimoxazol 50 mg/kg/day oral

For 7-10 days

Treatment can be adjusted according to the results of urine culture and sensitivity

2222....  Recurrent casesRecurrent casesRecurrent casesRecurrent cases: After eradication of infection the following should be done:

- Suppressive therapy with co-trimoxazol (Trimethoprim-sulfamethoxazole) given in lower

dose (one third of usual therapeutic dose)

- Adequate fluid intake

- Frequent voiding

- Avoid constipation

Nocturnal enuresisNocturnal enuresisNocturnal enuresisNocturnal enuresis- Identification & treatment of organic causesorganic causesorganic causesorganic causes e.g. urinary tract infection & polyuria

 

  Simple measures in children aboveSimple measures in children aboveSimple measures in children aboveSimple measures in children above 4444 yearsyearsyearsyears:

Page 8: Drugs in Pediatrics

5/16/2018 Drugs in Pediatrics - slidepdf.com

http://slidepdf.com/reader/full/drugs-in-pediatrics 8/18

 

Drugs in Pediatrics NMT11

www.MedadTeam.org 8

- Fluid restriction after dinner

- Let the child urinate before sleep

- Wake the child up by night to urinate- Rewarding for dry night

- Punishment should be avoided

  Drug therapy in children aboveDrug therapy in children aboveDrug therapy in children aboveDrug therapy in children above 6666 yearsyearsyearsyears:

 

OxybutyrinOxybutyrinOxybutyrinOxybutyrin Anticholinergic drugs increase bladder capacity

DesmopressinDesmopressinDesmopressinDesmopressin vasopressin analog single night dose 0.1-0.2 mg

Alarm deviceAlarm deviceAlarm deviceAlarm device it gives a ring immediately at the beginning of wetting so the child can wake up

for urination

Neurology

EpilepsyEpilepsyEpilepsyEpilepsyI-  Treatment of the ongoing seizures or treatment of status epilepticusTreatment of the ongoing seizures or treatment of status epilepticusTreatment of the ongoing seizures or treatment of status epilepticusTreatment of the ongoing seizures or treatment of status epilepticus.

 

•  First aid measuresFirst aid measuresFirst aid measuresFirst aid measures

-  Patent airway - O2 - IV line

•  Immediate anticonvulsant drugsImmediate anticonvulsant drugsImmediate anticonvulsant drugsImmediate anticonvulsant drugs

 

DiazepamDiazepamDiazepamDiazepam 0.3-0.5 mg/kg IV or rectal

PhenobarbitonePhenobarbitonePhenobarbitonePhenobarbitone 10-15 mg/kg (loading dose) that can be repeated

5 mg/kg (maintenance dose) after seizure control

If phenobarbitone failed to control the seizures shift to other drugs

 

PhenytoinPhenytoinPhenytoinPhenytoin 15-20 mg/kg (loading dose)

5 mg/kg/day (maintenance)

Na valproateNa valproateNa valproateNa valproate 20-40 mg rectally

IIIIIIII----  Prevention of recurrence by antiepileptic drugsPrevention of recurrence by antiepileptic drugsPrevention of recurrence by antiepileptic drugsPrevention of recurrence by antiepileptic drugs

 

-  DrugsDrugsDrugsDrugs:

 

DrugDrugDrugDrug Seizure typeSeizure typeSeizure typeSeizure type

 

Dose(mg/kg/day)Dose(mg/kg/day)Dose(mg/kg/day)Dose(mg/kg/day)

 

1111----  Sodium valproateSodium valproateSodium valproateSodium valproate

- Generalized seizures:

Tonic clonic, Absence and myoclonic

- Partial seizures

10-40

2222---- CarbamazepineCarbamazepineCarbamazepineCarbamazepine - Partial seizures: the best in partial seizures- Generalized tonic clonic

10-30

3333---- PhenobarbitonePhenobarbitonePhenobarbitonePhenobarbitone- Generalized tonic clonic

- Partial seizures3-5

4444---- PhenytoinPhenytoinPhenytoinPhenytoin As phenobarbitone 5-8

5555---- ClonazepamClonazepamClonazepamClonazepam- Myoclonic

- Infantile spasms0.05-0.1

6666---- EthosuximideEthosuximideEthosuximideEthosuximide- absence

- Myoclonic20-40

Page 9: Drugs in Pediatrics

5/16/2018 Drugs in Pediatrics - slidepdf.com

http://slidepdf.com/reader/full/drugs-in-pediatrics 9/18

 

Drugs in Pediatrics NMT11

www.MedadTeam.org 9

7777----  Vigabatrin Vigabatrin Vigabatrin Vigabatrin- Partial

- Infantile spasms

40-80

8888---- LamotrigineLamotrigineLamotrigineLamotrigine - Atypical absence seizures 5-109999---- TopiramateTopiramateTopiramateTopiramate - Partial seizures 5-10

10101010----  CorticosterioidsCorticosterioidsCorticosterioidsCorticosterioids

and ACTHand ACTHand ACTHand ACTH

- Infantile spasms, myoclonic seizures

- Symptomatic intractable seizures

-  IIIImportantmportantmportantmportant rulesrulesrulesrules for long term drug therapyfor long term drug therapyfor long term drug therapyfor long term drug therapy

 

1-  Initiation of therapy only after accurate diagnosis.

2-  Choice of drugs according to clinical and EEG findings.

3-  Number of drugs: start with one drug in small dose (to avoid toxicity and improve

compliance) then increases gradually until seizure control or maximum dose is reached

. Failure of the first drug is an indication to add the second drug.

4-  Duration and termination of therapy

 

At least 2 years after the child is being seizure free – termination should be gradually.

5-  Patent counseling

 

  Avoid watching TV except in lighted room and far enough from the screen.

  Computer games should be done under supervision

MeningitisMeningitisMeningitisMeningitis1111---- PreventionPreventionPreventionPrevention

---- Vaccination Vaccination Vaccination Vaccination

· Infants in the first year of life:- HIB vaccine HIB vaccine HIB vaccine HIB vaccine 3 33 3 doses doses doses doses (against Hemophilus influenza)

 

· Children:- Meningococcal polysaccharide vaccine (A and C) at Meningococcal polysaccharide vaccine (A and C) at Meningococcal polysaccharide vaccine (A and C) at Meningococcal polysaccharide vaccine (A and C) at 3 33 3 years years years years  

---- ChemoprophylaxisChemoprophylaxisChemoprophylaxisChemoprophylaxis· Rifampicin Rifampicin Rifampicin Rifampicin used to eradicate meningococci from the nasopharynx of carriers and

 

minimize the risk of contact infection.

2222---- Supportive treatmentSupportive treatmentSupportive treatmentSupportive treatment

 

- -- - I.V fluid I.V fluid I.V fluid I.V fluid if meningitis is complicated by shock (otherwise it should be restricted to minimize

cerebral edema)

- Blood transfusion for cases with DIC

- Anticonvulsants: diazepam and phenoparbitone diazepam and phenoparbitone diazepam and phenoparbitone diazepam and phenoparbitone  

3333---- Specific treatment: antibioticsSpecific treatment: antibioticsSpecific treatment: antibioticsSpecific treatment: antibiotics

Neonates 3 weeks Initial antibiotics should be active against

haemophilus influenzae type b, streptococci haemophilus influenzae type b, streptococci haemophilus influenzae type b, streptococci haemophilus influenzae type b, streptococci 

and menin and menin and menin and meningococci  gococci  gococci  gococci , then modified according

to the result of culture and sensitivity tests

IV IV IV IV for at least

10 10 10 10- -- - 14 14 14 14 days days days days  

Neonates and infants younger

than 2 months

Cefotriaxone Cefotriaxone Cefotriaxone Cefotriaxone   100 100 100 100 mg kg/day mg kg/day mg kg/day mg kg/day ,

ChloramphenicolChloramphenicolChloramphenicolChloramphenicol 100 100 100 100 mg kg/day mg kg/day mg kg/day mg kg/day ,

Ampicillin Ampicillin Ampicillin Ampicillin   100 100 100 100 mg kg/day mg kg/day mg kg/day mg kg/day ,

Infants and children older than

2 months

 

Third generation cephalosporin and cephalosporin and cephalosporin and cephalosporin and 

 

chloramphenicol chloramphenicol chloramphenicol chloramphenicol  

  N.B Corticosteroids for H influenza improve CSF findings and decrease the incidence of 

hearing loss 

Page 10: Drugs in Pediatrics

5/16/2018 Drugs in Pediatrics - slidepdf.com

http://slidepdf.com/reader/full/drugs-in-pediatrics 10/18

 

Drugs in Pediatrics NMT11

www.MedadTeam.org 10

4444---- Treatment of complicationsTreatment of complicationsTreatment of complicationsTreatment of complications

 

· Assisted ventilation if respiratory failure occurs.

· Subdural taps to evacuate extensive subdural effusions5555---- Follow up after treatmentFollow up after treatmentFollow up after treatmentFollow up after treatment

 

.Children who have meningitis should have a complete neurological evaluation at the time of 

discharge (vision, hearing and developmental assessment).

. Periodic follow up for at least 2 years is recommended.

Nutritional disorders

Protein energy malnutritionProtein energy malnutritionProtein energy malnutritionProtein energy malnutrition

  Prevention of protein energy malnutritionPrevention of protein energy malnutritionPrevention of protein energy malnutritionPrevention of protein energy malnutrition

1111---- Breast feeding Breast feeding Breast feeding Breast feeding promotion (it is the most important)

Enumerate factors important for successful breast feeding

2222---- Health education Health education Health education Health education of the mother about infant feeding

3333---- Assessment of nutritional status Assessment of nutritional status Assessment of nutritional status Assessment of nutritional status during infancy in every visit for earlier diagnosis of nutritional

deficiency disorders

  Management of protein energy malnutritionManagement of protein energy malnutritionManagement of protein energy malnutritionManagement of protein energy malnutrition

1111----Hospital managementHospital managementHospital managementHospital management

•  Indication

. 3rd

degree marasmus. Kwashiorkor or marasmic kwashiorkor (edema)

. Infections e.g. pneumonia, diarrhea

• Treatment of life threatening conditions is the initial line of management:-

. Control of infections Control of infections Control of infections Control of infections by proper antibiotics according to culture & sensitivity

. Correction of shock, dehydration & electrolyte imbalance Correction of shock, dehydration & electrolyte imbalance Correction of shock, dehydration & electrolyte imbalance Correction of shock, dehydration & electrolyte imbalance by proper I.V. fluids

. Correction of anemia Correction of anemia Correction of anemia Correction of anemia by blood or packed red cells 10-15cc/kg

. Prevention of hypothermia Prevention of hypothermia Prevention of hypothermia Prevention of hypothermia (adequate clothing & external heat)

2222----Home or hospital: nutritionalHome or hospital: nutritionalHome or hospital: nutritionalHome or hospital: nutritional management:management:management:management:

 

MarasmusMarasmusMarasmusMarasmus KwashiorkorKwashiorkorKwashiorkorKwashiorkor

TypeTypeTypeType . Milk Milk Milk Milk : in young non-weaned

infants

. Other foodOther foodOther foodOther food (balanced diet): in

older weaned infants

. Milk Milk Milk Milk : start with soy based lactose free

formula (lactose intolerance), then gradually

shift to standard formulas

. Other food Other food Other food Other food :

Animal protein (high biological value):

eggs, chicken, meat & yogurt

Plant protein: lentils, beans

Fresh vegetables & fruits are added

 

AmountAmountAmountAmount . 150-200 Kcal. / kg / day . High protein diet: 4-6 gram protein/kg/day

Page 11: Drugs in Pediatrics

5/16/2018 Drugs in Pediatrics - slidepdf.com

http://slidepdf.com/reader/full/drugs-in-pediatrics 11/18

 

Drugs in Pediatrics NMT11

www.MedadTeam.org 11

N.B:N.B:N.B:N.B:

calculation according to actual

body weight & gradually increase(5-10 Kcal/kg/day) every day or

every other day according to the

infant tolerance

RouteRouteRouteRoute Orally Orally Orally Orally  . Nasogastric tube Nasogastric tube Nasogastric tube Nasogastric tube  may be required if there

is marked anorexia

. Parentral feeding Parentral feeding Parentral feeding Parentral feeding  may be required in

severe cases

N.BN.BN.BN.B: Kwashiorkor Kwashiorkor Kwashiorkor Kwashiorkor (more difficult to manage because of anorexia)

Marasmus & kwashiorkorMarasmus & kwashiorkorMarasmus & kwashiorkorMarasmus & kwashiorkor 

- Treatment of vitamin & mineral deficiency

 

Vit Vit Vit Vit. A. A. A. A  Single doseSingle doseSingle doseSingle dose

50 000 IU (age up to 6 months)

100 000 IU (from 6 months to one year)

200 000 IU (more than one year)

Folic acid Folic acid Folic acid Folic acid – –– – iron iron iron iron   (4-6 mg/kg/day) in 3 doses

Others Others Others Others   vitamin D, C & B complex – minerals as (potassium & zinc)

- Treatment of parasitic infestations if present

 

RicketsRicketsRicketsRickets

 Preventive treatmentPreventive treatmentPreventive treatmentPreventive treatment:

  Vitamin D orally Vitamin D orally Vitamin D orally Vitamin D orally   daily from

the second month of life

Full termFull termFull termFull term: 400-800 IU

PretermPretermPretermPreterm: 1000-1500 IU from the age of one month

  Exposure to sun Exposure to sun Exposure to sun Exposure to sun  

  Diet rich in vitamin D Diet rich in vitamin D Diet rich in vitamin D Diet rich in vitamin D e.g. egg yolk, liver, oily fish

 Specific treatmentSpecific treatmentSpecific treatmentSpecific treatment::::

1111----Vitamin D therapy Vitamin D therapy Vitamin D therapy Vitamin D therapy Vitamin D deficiency rickets is sensitive to vitamin D in ordinary doses

 

Oral treatmentOral treatmentOral treatmentOral treatment I.M injectionI.M injectionI.M injectionI.M injection

Daily for 2-4 weeks Single injection without further therapy

 Vitamin D3 :2000-5000 IU/day

OROROROR

1.25 dihydroxycholecalciferol 0.5-2 Mg/day

600.000 IU

N.B N.B N.B N.B: If nononono healinghealinghealinghealing occurs the rickets is probably resistant to vitamin D resistant to vitamin D resistant to vitamin D resistant to vitamin D  

Page 12: Drugs in Pediatrics

5/16/2018 Drugs in Pediatrics - slidepdf.com

http://slidepdf.com/reader/full/drugs-in-pediatrics 12/18

 

Drugs in Pediatrics NMT11

www.MedadTeam.org 12

   N.B: N.B: N.B: N.B: Injection treatment may be better than oral treatment because of Injection treatment may be better than oral treatment because of Injection treatment may be better than oral treatment because of Injection treatment may be better than oral treatment because of:  

  More rapid healing

 

  Less dependence on parents for daily administration

 

  Earlier differential diagnosis from vitamin D resistant rickets

2222----Instructions to the parentsInstructions to the parentsInstructions to the parentsInstructions to the parents:

 Diet rich in vitamin D Diet rich in vitamin D Diet rich in vitamin D Diet rich in vitamin D  

  Proper sun exposure Proper sun exposure Proper sun exposure Proper sun exposure  

 Treatment of complicationsTreatment of complicationsTreatment of complicationsTreatment of complications:

-  Tetany Tetany Tetany Tetany: :: : 1ml/kg calcium gluconate 10% I.V slowly to be accompanied by oral calcium

-  Treatment of iron deficiency anemia Treatment of iron deficiency anemia Treatment of iron deficiency anemia Treatment of iron deficiency anemia by oral iron therapy 6 mg/kg/day

-  Deformities Deformities Deformities Deformities: surgical treatment if sever and persistent

 

Infections

RashesRashesRashesRashes

MeaslesMeaslesMeaslesMeasles Scarlet feverScarlet feverScarlet feverScarlet fever Chicken boxChicken boxChicken boxChicken box

PreventionPreventionPreventionPrevention • Active : measles measles measles measles 

vaccine vaccine vaccine vaccine (MMR)

• Passive: immune immune immune immune serum globulin serum globulin serum globulin serum globulin  

(0.25ml/kg IM)

within 5 days after

exposure. The dose

increased if delayed

beyond the 5th day.

Prevention of droplet droplet droplet droplet 

infection infection infection infection .• Live attenuated Live attenuated Live attenuated Live attenuated 

varicella vaccine varicella vaccine varicella vaccine varicella vaccine  is

being used

SupportiveSupportiveSupportiveSupportive

treatmenttreatmenttreatmenttreatment• Diet : increase fluid fluid fluid fluid  

intake

• Drugs Drugs Drugs Drugs :

 Cough : sedatives

 Fever : anti-pyretic Eye : eye drops

• Diet : increase fluid fluid fluid fluid 

intake

• Drugs Drugs Drugs Drugs : symptomatic

treatment

 Fever : anti-pyretic Headache & pain :

analgesics

• Itching Itching Itching Itching : local &

systemic anti-pruritic

agents

• Fever Fever Fever Fever : antipyretics-not

aspirin-as it increasesthe risk of Reye 

syndrome in which

there is acute

encephalopathy and

fatty degeneration of 

the viscera

 

SpecificSpecificSpecificSpecific

 

treatmenttreatmenttreatmenttreatment•  No specific No specific No specific No specific 

treatment treatment treatment treatment 

•  Large doses of 

• Penicillin : Penicillin : Penicillin : Penicillin :  is the

drug of choice : oral

penicillin V 400.000

• Antiviral drugs

(Acyclovir) (Acyclovir) (Acyclovir) (Acyclovir) in

immunocompromised

Page 13: Drugs in Pediatrics

5/16/2018 Drugs in Pediatrics - slidepdf.com

http://slidepdf.com/reader/full/drugs-in-pediatrics 13/18

 

Drugs in Pediatrics NMT11

www.MedadTeam.org 13

 gamma globulin  gamma globulin  gamma globulin  gamma globulin in

encephalitis

•  Oral vitamin Avitamin Avitamin Avitamin A( 400,000 IU)  in

severe cases

•  I.V vitamin Avitamin Avitamin Avitamin A for

measles affecting

kwashiorkor

IU/dose 3 times/day

for at least 10 days

• Erythromycin : Erythromycin : Erythromycin : Erythromycin : (40 mg/kg/day)

in penicillin sensitive

patients

patients

Treatment of Treatment of Treatment of Treatment of 

complicationscomplicationscomplicationscomplications

Otitis media &

bronchopneumonia

are treated by proper

antibiotics

Re-examination after 2-

3 weeks for detection

and management of 

remote complications

e.g. Rheumatic fever &

glomerulonephritis.

Skin infections: by proper

antibiotics

Rest of rashes:Rest of rashes:Rest of rashes:Rest of rashes:

1)  RubellaRubellaRubellaRubella : ttt is the same items as in measles

2)  Roseola infantumRoseola infantumRoseola infantumRoseola infantum :

•  Antipyretics

•  Sedatives to infants susceptible to febrile convulsions

3)  Infectious mononucleosisInfectious mononucleosisInfectious mononucleosisInfectious mononucleosis : No specific treatment

 

Rest of infectionsRest of infectionsRest of infectionsRest of infections

MumpsMumpsMumpsMumps TetanusTetanusTetanusTetanus DiphtheriaDiphtheriaDiphtheriaDiphtheria

PreventionPreventionPreventionPrevention • Active : Mumps Mumps Mumps Mumps 

vaccine or MMR vaccine or MMR vaccine or MMR vaccine or MMR  

• Passive : hyper hyper hyper hyper 

immune mumps immune mumps immune mumps immune mumps 

 gamma  gamma  gamma  gamma   globulins  globulins  globulins  globulins (of 

value if given early in

the incubation

period)

•  DPTDPTDPTDPT

•  Tetanus toxoid Tetanus toxoid Tetanus toxoid Tetanus toxoid during

pregnancy for

prevention of tetanus

neonatorum

•  Following injury : if not

immunized, human human human human 

antitetanus antitetanus antitetanus antitetanus 

immunoglobulin immunoglobulin immunoglobulin immunoglobulin  250-

500 units I.M or tetanus tetanus tetanus tetanus 

antitoxin antitoxin antitoxin antitoxin  3000 units

DPT vaccine DPT vaccine DPT vaccine DPT vaccine 

SupportiveSupportiveSupportiveSupportive

treatmenttreatmenttreatmenttreatment• MMMMeasures to relieveeasures to relieveeasures to relieveeasures to relieve

painpainpainpain:1.  Analgesics

2. Parotitis : heat to

the glands

3. Orchitis : ice bags

•  Isolation Isolation Isolation Isolation and nursing in

a dark quiet room

•  Control of convulsions Control of convulsions Control of convulsions Control of convulsions  

(patent airways,

oxygen, diazepam)

•  Maintenance of fluids Maintenance of fluids Maintenance of fluids Maintenance of fluids 

• Rest Rest Rest Rest : complete bed

rest if myocarditis is

diagnosed

• Proper hydration and Proper hydration and Proper hydration and Proper hydration and 

high caloric intake high caloric intake high caloric intake high caloric intake 

• Tube feeding Tube feeding Tube feeding Tube feeding  for

Page 14: Drugs in Pediatrics

5/16/2018 Drugs in Pediatrics - slidepdf.com

http://slidepdf.com/reader/full/drugs-in-pediatrics 14/18

 

Drugs in Pediatrics NMT11

www.MedadTeam.org 14

 – support the

testis

• MMMMouthouthouthouth: antisepticsolutions to keep it

clean

and electrolyte balance and electrolyte balance and electrolyte balance and electrolyte balance  palatal or pharyngeal

paralysis pt to avoid

aspiration

SpecificSpecificSpecificSpecific

treatmenttreatmenttreatmenttreatment

No specific treatment •  Human tetanus Human tetanus Human tetanus Human tetanus 

immunoglobulin immunoglobulin immunoglobulin immunoglobulin  5000500050005000----

10000100001000010000 I.M (single dose,

neither allergy nor

anaphylaxis and more

persistent titers)

•  Tetanus antitoxin Tetanus antitoxin Tetanus antitoxin Tetanus antitoxin  

50005000500050000-100001000010000100000U

(1/2I.M and ½ I.V) aftersensitivity test

•  Antibiotics to eradicate Antibiotics to eradicate Antibiotics to eradicate Antibiotics to eradicate 

the organism the organism the organism the organism: :: : penicillin

G 10000100001000010000U/Kg/day I.V

for 10days

•  Wound: cleaned, left Wound: cleaned, left Wound: cleaned, left Wound: cleaned, left 

opened and deprided opened and deprided opened and deprided opened and deprided 

1.  Antitoxin Antitoxin Antitoxin Antitoxin  to

neutralize the

exotoxin 40000-

100000 units I.M or

½ I.M and ½ I.V

after sensitivity test

2. Antibiotic Antibiotic Antibiotic Antibiotic to

eradicate the

organism•  Procaine penicillin Procaine penicillin Procaine penicillin Procaine penicillin  

600000 I.U for 7-

10 days

•  Erythromycin Erythromycin Erythromycin Erythromycin  40

mg/kg/day for 7-

10 days

(forsensitive pt)

 

Treatment of Treatment of Treatment of Treatment of 

complicationscomplicationscomplicationscomplications

Encephalitis : control

of convulsions and

measures to lower theincreased tension

Respiratory support for

cases with asphyxia

TTT of PertussisTTT of PertussisTTT of PertussisTTT of Pertussis :

•  Erythromycin Erythromycin Erythromycin Erythromycin: 50505050mg/kg/daymg/kg/daymg/kg/daymg/kg/day for 14 days may abort or eliminate the disease if given early.

 

GIT

 Vomiting & Persistent diarrhea Vomiting & Persistent diarrhea Vomiting & Persistent diarrhea Vomiting & Persistent diarrhea

 Vomiting Vomiting Vomiting Vomiting Persistent diarrheaPersistent diarrheaPersistent diarrheaPersistent diarrhea

-  Treatment of the cause

-  Antiemetic :

  Metoclopramide : 0.5mg / kg /day

inininin 3 33 3 divided doses divided doses divided doses divided doses  

  Dompridone : 1mg / kg /day inininin 3 33 3 

divided doses divided doses divided doses divided doses  

 Removal of the offending agent from diet Removal of the offending agent from diet Removal of the offending agent from diet Removal of the offending agent from diet e.g.

-  lactose : give instead lactose free formula

(Isomil)

-  Cow’s milk: give instead soy bean based

formula.

 Fat Fat Fat Fat given as medium chain triglycerides to

facilitate absorption.

 Vitamins Vitamins Vitamins Vitamins especially vitamin vitamin vitamin vitamin AAAA and trace elements

Page 15: Drugs in Pediatrics

5/16/2018 Drugs in Pediatrics - slidepdf.com

http://slidepdf.com/reader/full/drugs-in-pediatrics 15/18

 

Drugs in Pediatrics NMT11

www.MedadTeam.org 15

GastroenteritisGastroenteritisGastroenteritisGastroenteritis

1111----  Home management : mild to moderate casesHome management : mild to moderate casesHome management : mild to moderate casesHome management : mild to moderate cases•  Rehydration solutionsRehydration solutionsRehydration solutionsRehydration solutions: most imp. Item in management.

o  Principle: Glucose- facilitated Na absorption mechanism.

o  Composition:

NaCl:NaCl:NaCl:NaCl: 3.53.53.53.5 gmgmgmgm

 

To beTo beTo beTo be

dissolveddissolveddissolveddissolved

in onein onein onein one

literliterliterliter

Na:Na:Na:Na: 90909090mEq/LmEq/LmEq/LmEq/L

NaHCONaHCONaHCONaHCO3333:::: 2.52.52.52.5gmgmgmgm Cl :Cl :Cl :Cl : 80808080mEq/LmEq/LmEq/LmEq/L

KCl :KCl :KCl :KCl : 1.51.51.51.5 gmgmgmgm K:K:K:K: 20202020mEq/LmEq/LmEq/LmEq/L

Glucose :Glucose :Glucose :Glucose : 20202020 gmgmgmgm Glucose:Glucose:Glucose:Glucose:111111111111mmol/Lmmol/Lmmol/Lmmol/L

o  Indications

  All cases with mild and moderate dehydration

o  Dose  50-100 ml/kg according to the degree of dehydration to be given over 4-6 hours.

  Thirst mechanism is effective in regulating the amount giving to the child.

o  Method

  Usually given by spoon or cup.spoon or cup.spoon or cup.spoon or cup. 

  Nasogastric tube Nasogastric tube Nasogastric tube Nasogastric tube  may be used in case of:

a-  Refusal of ORS

b-  Newborn in an incubator

c-  Uncooperative mother

o  Advantages:

 Suitable for all age groups all age groups all age groups all age groups    All types of All types of All types of All types of diarrhea diarrhea diarrhea diarrhea 

  All types of All types of All types of All types of dehydration dehydration dehydration dehydration provided that Na level is between 115-165 mEq/L

•  FeedingFeedingFeedingFeeding:

 

 

Should not be delayed Should not be delayed Should not be delayed Should not be delayed  Delay repair of intestinal cells Persistant diarrhea

  Shortly after starting rehydration therapy

o  In breast fed infants: breast breast breast breast milk milk milk milk is given in small amounts and gradually increased

according to child's tolerance.

o  In formula fed infants: start with diluted formula diluted formula diluted formula diluted formula (1/4 strength) and increase the

conc. gradually.

o  In older children: gradual introduction of solid food solid food solid food solid food beginning with vegetables

fruits and jellies.•  Treatment of infectionTreatment of infectionTreatment of infectionTreatment of infection:  Self Self Self Self- -- -limited limited limited limited 

  Antibiotics may kill normal flora Antibiotics may kill normal flora Antibiotics may kill normal flora Antibiotics may kill normal flora  persistant diarrhea

o  Antibiotics are indicated in:

a-  Cholera

b-  Giardia, entameba,: Metronidazole 25252525mg/kg/daymg/kg/daymg/kg/daymg/kg/day( Giardia) and 50505050mg/kg/daymg/kg/daymg/kg/daymg/kg/day

(Entameba)

c-  Shigella

•  Symptomatic treatmentSymptomatic treatmentSymptomatic treatmentSymptomatic treatment

Page 16: Drugs in Pediatrics

5/16/2018 Drugs in Pediatrics - slidepdf.com

http://slidepdf.com/reader/full/drugs-in-pediatrics 16/18

 

Drugs in Pediatrics NMT11

www.MedadTeam.org 16

2222----  Hospital management for severe complicated casesHospital management for severe complicated casesHospital management for severe complicated casesHospital management for severe complicated cases

•  IndicationsIndicationsIndicationsIndications

o Deterioration Deterioration Deterioration Deterioration of the patient during home management

o  Severe dehydration dehydration dehydration dehydration or shock

o  Severe vomiting vomiting vomiting vomiting 

o  The presence of serious complications complications complications complications : septicemia, metabolic acidosis or bleeding.

AAAA----  Intravenous rehydrationIntravenous rehydrationIntravenous rehydrationIntravenous rehydration

 

Shock therapyShock therapyShock therapyShock therapy Deficit therapyDeficit therapyDeficit therapyDeficit therapy Maintenance therapyMaintenance therapyMaintenance therapyMaintenance therapy

( over 1111 hour) (over 8888 hrs) ( over 24242424 hrs)

Lactated ringer Lactated ringer Lactated ringer Lactated ringer 

sol.sol.sol.sol. ((((20202020 ml/ ml/ ml/ ml/kg)kg)kg)kg)

Glucose Glucose Glucose Glucose 5% 5% 5% 5% and saline in ratio and saline in ratio and saline in ratio and saline in ratio 1:1 1:1 1:1 1:1 

aaaa----  40404040ml/kg in mildmildmildmild dehydration

bbbb----  80808080ml/kg in moderatemoderatemoderatemoderate cases

cccc----  120120120120ml/kg in severesevereseveresevere dehydration

Glucose Glucose Glucose Glucose 5% 5% 5% 5% and saline in a ratio and saline in a ratio and saline in a ratio and saline in a ratio 4:1 4:1 4:1 4:1 

aaaa----  100100100100ml/kg for the firstfirstfirstfirst 10101010 kgkgkgkg

bbbb----  50505050ml/kg for each kg fromfromfromfrom 11111111----20202020 kgkgkgkg

cccc----  20202020ml/kg for each kg aboveaboveaboveabove 20202020 kgkgkgkg

  Deficit therapyDeficit therapyDeficit therapyDeficit therapy in hypernatremic dehydration is made with only 70% of the

calculated amount and should be given slowly to prevent brain edema.

  PotassiumPotassiumPotassiumPotassium therapytherapytherapytherapy: potassium chloride solution (15%) is added to deficit and

maintenance therapy: 1111mlmlmlml for eachfor eachfor eachfor each 100100100100 mlmlmlml solution to correct hypokalemia.

BBBB----  TreatmentTreatmentTreatmentTreatment of complicationsof complicationsof complicationsof complications

 

Painful oral lesionPainful oral lesionPainful oral lesionPainful oral lesion

Monilial stomatitisMonilial stomatitisMonilial stomatitisMonilial stomatitis Herpetic gingivostomatitisHerpetic gingivostomatitisHerpetic gingivostomatitisHerpetic gingivostomatitis HHHHerpanginaerpanginaerpanginaerpangina

Antifungal oral nystatin

(mucostatin) or oral

miconazol (daktarin oral gel)

for 10 days

SymptomaticSymptomaticSymptomaticSymptomatic oral analgesics

&antipyretics.

. Antiviral agents are not

indicated

SymptomaticSymptomaticSymptomaticSymptomatic

Hematology

Thalathemia majorThalathemia majorThalathemia majorThalathemia major

1111----Correction of anemiaCorrection of anemiaCorrection of anemiaCorrection of anemia 2222----Removal & prevention of iron ovRemoval & prevention of iron ovRemoval & prevention of iron ovRemoval & prevention of iron overload byerload byerload byerload by

iron chelating agentsiron chelating agentsiron chelating agentsiron chelating agents

• Packed RBCs transfusionPacked RBCs transfusionPacked RBCs transfusionPacked RBCs transfusion

-10-15 ml/ kg/ every 4-5 weeks to maintain

Hb level above 10 gm% (hypertransfusion)

• Folic acidFolic acidFolic acidFolic acid

To prevent megaloplastic changes in thebone marrow 

DyferoxamineDyferoxamineDyferoxamineDyferoxamine:::: SC by a pump over 10hours 5-6 nights/ week

DeferiproneDeferiproneDeferiproneDeferiprone:::: oral chelating drug used

when complications of dyferoxamine occur

Page 17: Drugs in Pediatrics

5/16/2018 Drugs in Pediatrics - slidepdf.com

http://slidepdf.com/reader/full/drugs-in-pediatrics 17/18

 

Drugs in Pediatrics NMT11

www.MedadTeam.org 17

3333----  SplenectomySplenectomySplenectomySplenectomy

 

IndicationsIndicationsIndicationsIndications -Hypersplenism

-Huge spleen causing pressure symptoms

TimingTimingTimingTiming Should not be done before 4 years to avoid sepsis

Care afterCare afterCare afterCare after

splenectomysplenectomysplenectomysplenectomy

-Vaccination against pneumococci, meningiococci & haemophilus

influenza b

-Long acting penicillin

4444----  Recent treatmentRecent treatmentRecent treatmentRecent treatment ::::

Bone marrow transplantation using marrow cells or peripheral stem cells

Induction of fetal Hb production by drugs e.g. L-carnitine

Gene therapy is under trial

Iron deficiency anemiaIron deficiency anemiaIron deficiency anemiaIron deficiency anemia

 PreventionPreventionPreventionPrevention::::

- Adequate supply of iron to iron to iron to iron to mother mother mother mother during pregnancy

- Proper weaning: iron containing food iron containing food iron containing food iron containing food (green vegetables or meat products) should be given

to infant from age 6th month

- Ear Ear Ear Early ly ly ly diagnosis and treatment of the cause diagnosis and treatment of the cause diagnosis and treatment of the cause diagnosis and treatment of the cause e.g. Parasitic infestation-bleeding

 Specific treatmentSpecific treatmentSpecific treatmentSpecific treatment:::: Iron therapyIron therapyIron therapyIron therapy  

 

OralOralOralOral IntramuscularIntramuscularIntramuscularIntramuscularIndicationsIndicationsIndicationsIndications the usual route failure of oral route

PreparationsPreparationsPreparationsPreparations ferrous sulfate-ferrous gluconate iron dextran

DoseDoseDoseDose 6666mg/kg/daymg/kg/daymg/kg/daymg/kg/day 3 doses between meals 1111ml(ml(ml(ml(50505050mg)mg)mg)mg) in infant-2ml(100mg) in

young children

CourseCourseCourseCourse 4444----6666 weaksweaksweaksweaks after normalization of all

blood values to replete stores

3333 totototo5555 daysdaysdaysdays

  Supportive treatmentSupportive treatmentSupportive treatmentSupportive treatment::::

Blood transfusion (packed red cells: 10101010 ml/kg slowlyml/kg slowlyml/kg slowlyml/kg slowly) in impending heart failure or when there

is serious infection

 

Immune thrombocytopenic purpura (ITP)Immune thrombocytopenic purpura (ITP)Immune thrombocytopenic purpura (ITP)Immune thrombocytopenic purpura (ITP)

Moderate and severeModerate and severeModerate and severeModerate and severe Number belowbelowbelowbelow 20202020,,,,000000000000 or mucous membrane bleeding

1111----  SteroidsSteroidsSteroidsSteroids 2222----  IV Ig or anti D:IV Ig or anti D:IV Ig or anti D:IV Ig or anti D:

ActionActionActionAction inhibit Ab synthesis & reduce capillary

fragility

bind antibodies before attacking

platelets

DoseDoseDoseDose 1-2 mg / kg /day 400 /kg over 4-8 hours

Page 18: Drugs in Pediatrics

5/16/2018 Drugs in Pediatrics - slidepdf.com

http://slidepdf.com/reader/full/drugs-in-pediatrics 18/18

 

Drugs in Pediatrics NMT11

www.MedadTeam.org 18

DurationDurationDurationDuration until platelet count is normal or for 3

weeks which ever comes first

5 consecutive days , booster doses very

2-4 weeks may be needed

ExcellentExcellentExcellentExcellentresponseresponseresponseresponse

Rapid control of serious bleedingespecially postoperative in steroid

resistant cases. platelet count increase in

7-14 days after therapy

3333----  Transfusion therapyTransfusion therapyTransfusion therapyTransfusion therapy

4444----  SplenectomySplenectomySplenectomySplenectomy in chronic cases who are steroid resistant

5555----  ImmunosuppressiveImmunosuppressiveImmunosuppressiveImmunosuppressive e.g. azathioprine or cyclosporine in resistant cases who failed to respond

to splenectomy or relapse postoperatively

6666----  PlasmapharesisPlasmapharesisPlasmapharesisPlasmapharesis transient effect if all measures failed